Furthermore, this group showed that the calcineurin inhibitor, tacrolimus, inhibited RANKL expression in RA-FLS by suppressing STAT3, but most importantly SOCS-3 was also induced by tacrolimus. The gene discussed is SOCS3; the disease is rheumatoid arthritis.